Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Teva Pharmaceutical Industries Ltd (TEVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 32,205,632
  • Shares Outstanding, K 1,014,990
  • Annual Sales, $ 21,903 M
  • Annual Income, $ 329,000 K
  • 36-Month Beta 0.63
  • Price/Sales 1.45
  • Price/Cash Flow 4.75
  • Price/Book 1.01

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.22 +4.50%
on 04/25/17
33.24 -4.99%
on 03/29/17
-1.38 (-4.19%)
since 03/28/17
3-Month
30.22 +4.50%
on 04/25/17
37.94 -16.76%
on 02/21/17
-3.01 (-8.70%)
since 01/27/17
52-Week
30.22 +4.50%
on 04/25/17
56.44 -44.05%
on 07/13/16
-23.41 (-42.57%)
since 04/28/16

Most Recent Stories

More News
Teva Announces Publication of ARM-TD Study Results in Neurology(R) for the Investigational Use of Deutetrabenazine in Tardive Dyskinesia

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced the publication of results from the Phase II/III study ARM-TD (Aim to Reduce Movements in Tardive Dyskinesia)...

TEVA : 31.58 (-0.47%)
Teva Announces Launch of Generic Vytorin(R) in the United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the launch of generic Vytorin(R)1 (ezetimibe and simvastatin) tablets in the U.S.

TEVA : 31.58 (-0.47%)
Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today confirmed that Eyal Desheh, Group Executive Vice President, Chief Financial Officer, will depart from Teva during the coming...

TEVA : 31.58 (-0.47%)
Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TG Therapeutics

NEW YORK, NY / ACCESSWIRE / April 26, 2017 / Strong corporate earnings continued to drive markets higher Tuesday. The NASDAQ Composite Index topped the 6,000 mark for the first time ever, hitting a high...

TGTX : 11.05 (-7.53%)
TEVA : 31.58 (-0.47%)
Teva Pharmaceutical Industries Rises 2.15% on Heavy Volume: Watch For Potential Pullback

Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $31.40 to a high of $31.87. Yesterday, the shares gained 2.2%, which took the trading range above the...

TEVA : 31.58 (-0.47%)
Look for Shares of Teva Pharmaceutical Industries to Potentially Pullback after Yesterday's 2.15% Rise

Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $31.40 to a high of $31.87. Yesterday, the shares gained 2.2%, which took the trading range above the...

TEVA : 31.58 (-0.47%)
Global Tamoxifen Market to Reach $683.6 Million by 2022: Key Vendors are AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex & Midatech - Research and Markets

Research and Markets has announced the addition of the "Global Tamoxifen Market - 2014 to 2022" report to their offering.

AGN : 243.86 (+0.33%)
TEVA : 31.58 (-0.47%)
Teva Launches AirDuo(TM) RespiClick(R) and its Authorized Generic, Two Inhalers Containing Fluticasone Propionate and Salmeterol

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the simultaneous launch of AirDuo(TM) RespiClick(R) (fluticasone propionate and salmeterol) inhalation powder and...

TEVA : 31.58 (-0.47%)
Look for Shares of Teva Pharmaceutical Industries to Potentially Rebound after Yesterday's 3.68% Sell Off

Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $30.91 to a high of $31.94. Yesterday, the shares fell 3.7%, which took the trading range below the...

TEVA : 31.58 (-0.47%)
Did Pharma & Biotech M&As Pick Pace in Q1?

Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.

JNJ : 123.47 (-0.22%)
AGN : 243.86 (+0.33%)
SHPG : 176.96 (-0.49%)
GILD : 68.55 (-0.04%)
TEVA : 31.58 (-0.47%)
PFE : 33.92 (+0.18%)
SNY : 47.30 (+0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended...

See More

Support & Resistance

2nd Resistance Point 32.25
1st Resistance Point 31.91
Last Price 31.58
1st Support Level 31.27
2nd Support Level 30.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.